Consolidated Statements Of Cash Flows - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities:
Net (loss) income	$ (6,043)	$ (320,724)	$ (53,154)	$ 317,220	$ (326,767)	$ 264,066
Accounts Receivable, Credit Loss Expense (Reversal)					20,000	15,000
Other Noncash Income (Expense)					0	506,305
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization					22,865	25,450
us-gaap_OtherNonoperatingIncomeExpensenoncash					0	(506,305)
Change in operating assets and liabilities:
Increaser(Decrease) in Accounts Receivable					333,327	(267,804)
Increase (Decrease) in Inventories					(279,576)	(28,789)
Increase (Decrease) in Other Operating Assets					17,923	(21,913)
Increase (Decrease) in Deferred Revenue					(73,556)	(53,511)
Increase (Decrease) in Accounts Payable					309,242	(53,197)
Increase (Decrease) in Accrued Liabilities					(242,887)	95,537
Increase (Decrease) in Other Operating Liabilities					(149,155)	(142,934)
Other Operating Activities, Cash Flow Statement					142,790	138,453
Increase (Decrease) in Other Deferred Liability					(44,802)	(45,500)
Net Cash Provided by (Used in) Operating Activities					(270,596)	(581,447)
Cash Flows from Investing Activities:
Payments to Acquire Intangible Assets					(7,155)	0
Net Cash Provided by (Used in) Investing Activities					(7,155)	0
Net Cash provided by (used in) Financing Activities:
Repayments of Notes Payable					(2,089)	(1,937)
Repayment of EIDL loan					(488)	(1,448)
Net Cash Provided by (Used in) Financing Activities					(2,577)	(3,385)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect					(280,328)	(584,832)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning of Period		$ 850,034		$ 1,906,890	850,034	1,906,890	$ 1,906,890
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period	569,706		1,322,058		569,706	1,322,058	850,034
Cash and cash equivalents	313,498		1,065,956		313,498	1,065,956	593,869	$ 1,650,970
Restricted Cash	256,208		256,102		256,208	256,102	256,165	255,920
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 569,706		$ 1,322,058		569,706	1,322,058	$ 850,034	$ 1,906,890
Supplemental Schedule of Cash Flow Information:
Interest Paid, Excluding Capitalized Interest, Operating Activities					$ 11,351	$ 8,400
Weighted average shares - basic	7,415,329		7,415,329		7,415,329	7,415,329